English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, May 17, 2019
"Science Based Targets (SBT) Initiative" Approves Eisai's Greenhouse Gas Reduction Targets
エーザイの温室効果ガス削減目標が「Science Based Targets(SBT)イニシアチブ」から承認の取得
Thursday, May 16, 2019
エーザイ、第55回米国臨床腫瘍学会年次総会でレンバチニブメシル酸塩などに関する最新データを発表
Eisai to Present Data on Oncology Pipeline and Products at 55th Asco Annual Meeting
Tuesday, May 14, 2019
エーザイ、代表執行役の異動に関するお知らせ
Friday, May 10, 2019
Eisai Enters Into Licensing Agreement With Medac Concerning Anti-Rheumatic Agent Methotrexate Subcutaneous Injection in Japan
Eisai: Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401
Thursday, May 9, 2019
エーザイとアルム、ICTを活用したヘルスケアソリューションにおける資本業務提携契約を締結
エーザイ、創薬イノベーションおよびエコシステム プラットフォーム構築の加速に向けたベンチャー投資事業を開始
Eisai and Allm Enter Into Capital and Business Alliance Agreement for ICT Healthcare Solutions

Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8400